New CT finding (the target sign) in three patients with COVID-19 pneumonia

Martins, Rosane Rodrigues; Santana, Vanessa Garcia; Souza, Daniel Lima; Reinaux, Juliana Cavalcanti de Freitas

doi:10.36416/1806-3756/e20200413

Search citation statements

Order By: Relevance

Paper Sections

Select...

Ao Editor1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2021

2022

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(2) Entretanto, outros achados tomográficos podem estar presentes na COVID-19, como o sinal do halo invertido, o sinal do alvo e, finalmente, achados de embolia pulmonar. (3)(4)(5)(6) Pelo que sabemos, este é o segundo relato na literatura internacional de um caso de paciente com COVID-19 com padrão de infiltrado pulmonar migratório, compatível com pneumonia em organização (PO), que apresentou boa e rápida resposta ao tratamento com corticoide. (7) Paciente do sexo feminino, 47 anos de idade e com diagnóstico de linfoma folicular foi reavaliada no 33º dia de sintomas relacionados à COVID-19.…”

Section: Ao Editorunclassified

Migratory pulmonary infiltrates in a patient with COVID-19 and lymphoma

et al. 2021

View full text Add to dashboard Cite

Section: Ao Editorunclassified

Migratory pulmonary infiltrates in a patient with COVID-19 and lymphoma

et al. 2021

View full text Add to dashboard Cite

Pulmonary fibrosis secondary to COVID-19: a narrative review

Tanni

Fabro

Albuquerque

et al. 2021

Expert Review of Respiratory Medicine

View full text Add to dashboard Cite

SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments

et al. 2022

View full text Add to dashboard Cite

Since the SARS-CoV-2 outbreak, pharmaceutical companies and researchers worldwide have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The potential pathogen responsible for Coronavirus Disease 2019 (COVID-19), SARS-CoV-2, belongs to a novel lineage of beta coronaviruses in the subgenus arbovirus. Antiviral drugs, convalescent plasma, monoclonal antibodies, and vaccines are effective treatments for SARS-CoV-2 and are beneficial in preventing infection. Numerous studies have already been conducted using the genome sequence of SARS-CoV-2 in comparison with that of other SARS-like viruses, and numerous treatments/prevention measures are currently undergoing or have already undergone clinical trials. We summarize these studies in depth in the hopes of highlighting some key details that will help us to better understand the viral origin, epidemiology, and treatments of the virus.

show abstract

New CT finding (the target sign) in three patients with COVID-19 pneumonia

Cited by 3 publications

References 5 publications

Migratory pulmonary infiltrates in a patient with COVID-19 and lymphoma

Migratory pulmonary infiltrates in a patient with COVID-19 and lymphoma

Pulmonary fibrosis secondary to COVID-19: a narrative review

SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments

Contact Info

Product

Resources

About